Eli Lilly 6 may 2026 Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility - Eli Lilly
Thermo Fisher 6 may 2026 Thermo Fisher Scientific’s Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials - The Joplin Globe
FierceBiotech 6 may 2026 GSK pens $1B deal with China’s SiranBio for oligonucleotide that could reduce abdominal fat
Thermo Fisher 6 may 2026 Thermo Fisher Scientific’s Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials - Yahoo Finance
FierceBiotech 6 may 2026 CellCentric raises $220M series D to advance myeloma drug through registration, eyes potential IPO
FierceBiotech 6 may 2026 Novo CEO insists ‘no change in plan’ for CagriSema launch after single-chamber device ditched
FierceBiotech 6 may 2026 Avalo’s phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind
Recursion 6 may 2026 After a decade of hype, Najat Khan is bringing Recursion back down to earth - Fierce Biotech